| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT USE IN UNAPPROVED INDICATION | 619 |
| 1 | OFF LABEL USE | 208 |
| 2 | ADAMTS13 ACTIVITY DECREASED | 161 |
| 3 | EPISTAXIS | 133 |
| 4 | PLATELET COUNT DECREASED | 133 |
| 5 | FATIGUE | 111 |
| 6 | CONTUSION | 89 |
| 7 | THROMBOTIC THROMBOCYTOPENIC PURPURA | 84 |
| 8 | HEADACHE | 83 |
| 9 | INJECTION SITE PAIN | 82 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | ADAMTS13 INHIBITOR SCREEN ASSAY | 3 | 1.0000 |
| 1 | ADAMTS13 ACTIVITY ASSAY | 1 | 1.0000 |
| 2 | ADAMTS13 ACTIVITY ABNORMAL | 73 | 0.8022 |
| 3 | PLACENTAL OEDEMA | 8 | 0.7273 |
| 4 | ADAMTS13 ACTIVITY DECREASED | 161 | 0.6216 |
| 5 | HAEMORRHAGIC PANCREATIC CYST | 1 | 0.5000 |
| 6 | ADAMTS13 ACTIVITY INCREASED | 4 | 0.5000 |
| 7 | POST TRANSFUSION PURPURA | 2 | 0.2500 |
| 8 | COMPRESSION GARMENT APPLICATION | 1 | 0.1111 |
| 9 | BLOOD GLUCAGON DECREASED | 1 | 0.0833 |